10:57 AM EST - BioVaxys Technology Corp : Announces it has appointed Christopher Cherry as Chief Financial Officer. Mr. Cherry, a Chartered Accountant and Certified Public Accountant, has extensive experience, having served as a CFO of many public issuers in a broad range of sectors. Mr. Cherry has previously worked as a Senior Auditor with Davidson & Company LLP and a Senior Accountant with KPMG LLP. BioVaxys Technology Corp
shares C.BIOV are trading unchanged at $0.07.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BIOV%3ACC&qmodStoryID=5680712810616543
